APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronary Pathway Products

Compare research editions
View pricing & licenses

Selected research

Industry Research

Coronary Pathway Products Industry Research Report 2026

24 December 2025143 pages

Choose your research edition.

Industry ResearchCoronary Pathway Products Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronary Pathway Products Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Coronary Pathway Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronary Pathway Products Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronary Pathway Products Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Coronary Pathway Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Coronary Pathway Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Coronary Pathway Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Coronary Pathway Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Coronary Pathway Products include Medtronic, Terumo Corporation, Boston Scientific, Cordis, Abbott, Merit Medical, Curatia Medical, ASAHI INTECC and Zhejiang Barty Medical Technology, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Coronary Pathway Products market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Coronary Pathway Products.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Coronary Pathway Products Market by Company

Medtronic

Terumo Corporation

Boston Scientific

Cordis

Abbott

Merit Medical

Curatia Medical

ASAHI INTECC

Zhejiang Barty Medical Technology

OrbusNeich Medical Company

MicroPort Scientific Corporation

Suzhou Innomed Medical Device

Shunmei Medical

Shenzhen MicroApproach Medical Technology

Shanghai INT Medical Instruments

Xiamen New Concept Medical Technology

Lepu Medical Technology

APT Medical

BrosMed Medical

Beijing Demax Medical Technology

Jiangsu ChangMei Medtech

Jiangxi Hongda Medical Equipment Group

Changzhou JIUHONG Medical Instrument

Coronary Pathway Products Segment by Type

Catheter Sheath Set

Arterial Compression Tourniquet

Balloon Dilation Pressure Pump

Microcatheter

Micro Guide Wire

Contrast Catheter

Contrast Guide Wire

Guiding Catheter

Y-Shaped Connector

Others

Coronary Pathway Products Segment by Application

Hospital

Clinic

Others

Coronary Pathway Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Pathway Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronary Pathway Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Pathway Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Coronary Pathway Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Coronary Pathway Products Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Coronary Pathway Products Revenue Market Share by Type (2021-2026) Table 7. Global Coronary Pathway Products Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Coronary Pathway Products Revenue Market Share by Type (2027-2032) Table 9. Global Coronary Pathway Products Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Coronary Pathway Products Revenue Market Share by Application (2021-2026) Table 11. Global Coronary Pathway Products Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Coronary Pathway Products Revenue Market Share by Application (2027-2032) Table 13. Global Coronary Pathway Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Coronary Pathway Products Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Coronary Pathway Products Market Share by Region (2021-2026) Table 16. Global Coronary Pathway Products Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Coronary Pathway Products Market Share by Region (2027-2032) Table 18. Coronary Pathway Products Industry Trends Table 19. Coronary Pathway Products Industry Drivers Table 20. Coronary Pathway Products Industry Opportunities and Challenges Table 21. Coronary Pathway Products Market Restraints Table 22. Global Top Coronary Pathway Products Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Coronary Pathway Products Revenue Market Share by Players (2021-2026) Table 24. Global Coronary Pathway Products Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Coronary Pathway Products, Headquarters and Area Served Table 26. Global Coronary Pathway Products Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Coronary Pathway Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Coronary Pathway Products Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Coronary Pathway Products Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Coronary Pathway Products Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Coronary Pathway Products Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Coronary Pathway Products Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Coronary Pathway Products Market Size by Country (2027-2032) & (US$ Million) Table 45. Medtronic Company Information Table 46. Medtronic Business Overview Table 47. Medtronic Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 48. Medtronic Coronary Pathway Products Product Portfolio Table 49. Medtronic Recent Developments Table 50. Terumo Corporation Company Information Table 51. Terumo Corporation Business Overview Table 52. Terumo Corporation Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 53. Terumo Corporation Coronary Pathway Products Product Portfolio Table 54. Terumo Corporation Recent Developments Table 55. Boston Scientific Company Information Table 56. Boston Scientific Business Overview Table 57. Boston Scientific Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 58. Boston Scientific Coronary Pathway Products Product Portfolio Table 59. Boston Scientific Recent Developments Table 60. Cordis Company Information Table 61. Cordis Business Overview Table 62. Cordis Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 63. Cordis Coronary Pathway Products Product Portfolio Table 64. Cordis Recent Developments Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 68. Abbott Coronary Pathway Products Product Portfolio Table 69. Abbott Recent Developments Table 70. Merit Medical Company Information Table 71. Merit Medical Business Overview Table 72. Merit Medical Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 73. Merit Medical Coronary Pathway Products Product Portfolio Table 74. Merit Medical Recent Developments Table 75. Curatia Medical Company Information Table 76. Curatia Medical Business Overview Table 77. Curatia Medical Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 78. Curatia Medical Coronary Pathway Products Product Portfolio Table 79. Curatia Medical Recent Developments Table 80. ASAHI INTECC Company Information Table 81. ASAHI INTECC Business Overview Table 82. ASAHI INTECC Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 83. ASAHI INTECC Coronary Pathway Products Product Portfolio Table 84. ASAHI INTECC Recent Developments Table 85. Zhejiang Barty Medical Technology Company Information Table 86. Zhejiang Barty Medical Technology Business Overview Table 87. Zhejiang Barty Medical Technology Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 88. Zhejiang Barty Medical Technology Coronary Pathway Products Product Portfolio Table 89. Zhejiang Barty Medical Technology Recent Developments Table 90. OrbusNeich Medical Company Company Information Table 91. OrbusNeich Medical Company Business Overview Table 92. OrbusNeich Medical Company Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 93. OrbusNeich Medical Company Coronary Pathway Products Product Portfolio Table 94. OrbusNeich Medical Company Recent Developments Table 95. MicroPort Scientific Corporation Company Information Table 96. MicroPort Scientific Corporation Business Overview Table 97. MicroPort Scientific Corporation Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 98. MicroPort Scientific Corporation Coronary Pathway Products Product Portfolio Table 99. MicroPort Scientific Corporation Recent Developments Table 100. Suzhou Innomed Medical Device Company Information Table 101. Suzhou Innomed Medical Device Business Overview Table 102. Suzhou Innomed Medical Device Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 103. Suzhou Innomed Medical Device Coronary Pathway Products Product Portfolio Table 104. Suzhou Innomed Medical Device Recent Developments Table 105. Shunmei Medical Company Information Table 106. Shunmei Medical Business Overview Table 107. Shunmei Medical Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 108. Shunmei Medical Coronary Pathway Products Product Portfolio Table 109. Shunmei Medical Recent Developments Table 110. Shenzhen MicroApproach Medical Technology Company Information Table 111. Shenzhen MicroApproach Medical Technology Business Overview Table 112. Shenzhen MicroApproach Medical Technology Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 113. Shenzhen MicroApproach Medical Technology Coronary Pathway Products Product Portfolio Table 114. Shenzhen MicroApproach Medical Technology Recent Developments Table 115. Shanghai INT Medical Instruments Company Information Table 116. Shanghai INT Medical Instruments Business Overview Table 117. Shanghai INT Medical Instruments Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 118. Shanghai INT Medical Instruments Coronary Pathway Products Product Portfolio Table 119. Shanghai INT Medical Instruments Recent Developments Table 120. Xiamen New Concept Medical Technology Company Information Table 121. Xiamen New Concept Medical Technology Business Overview Table 122. Xiamen New Concept Medical Technology Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 123. Xiamen New Concept Medical Technology Coronary Pathway Products Product Portfolio Table 124. Xiamen New Concept Medical Technology Recent Developments Table 125. Lepu Medical Technology Company Information Table 126. Lepu Medical Technology Business Overview Table 127. Lepu Medical Technology Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 128. Lepu Medical Technology Coronary Pathway Products Product Portfolio Table 129. Lepu Medical Technology Recent Developments Table 130. APT Medical Company Information Table 131. APT Medical Business Overview Table 132. APT Medical Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 133. APT Medical Coronary Pathway Products Product Portfolio Table 134. APT Medical Recent Developments Table 135. BrosMed Medical Company Information Table 136. BrosMed Medical Business Overview Table 137. BrosMed Medical Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 138. BrosMed Medical Coronary Pathway Products Product Portfolio Table 139. BrosMed Medical Recent Developments Table 140. Beijing Demax Medical Technology Company Information Table 141. Beijing Demax Medical Technology Business Overview Table 142. Beijing Demax Medical Technology Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 143. Beijing Demax Medical Technology Coronary Pathway Products Product Portfolio Table 144. Beijing Demax Medical Technology Recent Developments Table 145. Jiangsu ChangMei Medtech Company Information Table 146. Jiangsu ChangMei Medtech Business Overview Table 147. Jiangsu ChangMei Medtech Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 148. Jiangsu ChangMei Medtech Coronary Pathway Products Product Portfolio Table 149. Jiangsu ChangMei Medtech Recent Developments Table 150. Jiangxi Hongda Medical Equipment Group Company Information Table 151. Jiangxi Hongda Medical Equipment Group Business Overview Table 152. Jiangxi Hongda Medical Equipment Group Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 153. Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Product Portfolio Table 154. Jiangxi Hongda Medical Equipment Group Recent Developments Table 155. Changzhou JIUHONG Medical Instrument Company Information Table 156. Changzhou JIUHONG Medical Instrument Business Overview Table 157. Changzhou JIUHONG Medical Instrument Revenue in Coronary Pathway Products Business (2021-2026) & (US$ Million) Table 158. Changzhou JIUHONG Medical Instrument Coronary Pathway Products Product Portfolio Table 159. Changzhou JIUHONG Medical Instrument Recent Developments Table 160. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Coronary Pathway Products Product Image Figure 5. Global Coronary Pathway Products Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Coronary Pathway Products Market Share by Type: 2025 VS 2032 Figure 7. Catheter Sheath Set Product Figure 8. Arterial Compression Tourniquet Product Figure 9. Balloon Dilation Pressure Pump Product Figure 10. Microcatheter Product Figure 11. Micro Guide Wire Product Figure 12. Contrast Catheter Product Figure 13. Contrast Guide Wire Product Figure 14. Guiding Catheter Product Figure 15. Y-Shaped Connector Product Figure 16. Others Product Figure 17. Global Coronary Pathway Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Coronary Pathway Products Market Share by Application: 2025 VS 2032 Figure 19. Hospital Product Figure 20. Clinic Product Figure 21. Others Product Figure 22. Global Coronary Pathway Products Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 23. Global Coronary Pathway Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 24. Global Coronary Pathway Products Market Share by Region: 2025 VS 2032 Figure 25. Global Coronary Pathway Products Market Share by Players in 2025 Figure 26. Global Coronary Pathway Products Manufacturers Established Date Figure 27. Global Top 5 and 10 Coronary Pathway Products Players Market Share by Revenue in 2025 Figure 28. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. North America Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Coronary Pathway Products Market Share by Country (2021-2032) Figure 31. United States Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Canada Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Mexico Coronary Pathway Products Market Share by Country (2021-2032) Figure 34. Europe Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Coronary Pathway Products Market Share by Country (2021-2032) Figure 36. Germany Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. France Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. U.K. Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Italy Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Spain Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Russia Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Netherlands Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Nordic Countries Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia-Pacific Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia-Pacific Coronary Pathway Products Market Share by Country (2021-2032) Figure 46. China Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Japan Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South Korea Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. India Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. India Coronary Pathway Products Market Share by Country (2021-2032) Figure 51. Australia Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. China Taiwan Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Southeast Asia Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. South America Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. South America Coronary Pathway Products Market Share by Country (2021-2032) Figure 56. Brazil Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Argentina Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 58. Chile Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 59. Colombia Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 60. Peru Coronary Pathway Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 61. Medtronic Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 62. Terumo Corporation Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 63. Boston Scientific Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 64. Cordis Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 65. Abbott Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 66. Merit Medical Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 67. Curatia Medical Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 68. ASAHI INTECC Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 69. Zhejiang Barty Medical Technology Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 70. OrbusNeich Medical Company Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 71. MicroPort Scientific Corporation Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 72. Suzhou Innomed Medical Device Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 73. Shunmei Medical Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 74. Shenzhen MicroApproach Medical Technology Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 75. Shanghai INT Medical Instruments Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 76. Xiamen New Concept Medical Technology Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 77. Lepu Medical Technology Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 78. APT Medical Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 79. BrosMed Medical Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 80. Beijing Demax Medical Technology Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 81. Jiangsu ChangMei Medtech Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 82. Jiangxi Hongda Medical Equipment Group Revenue Growth Rate in Coronary Pathway Products Business (2021-2026) Figure 83. Changzhou JIUHONG Medical Instrument Revenue Growth Rate in Coronary Pathway Products Business (2021-2026)

Scope & coverage.

Types
  • Catheter Sheath Set
  • Arterial Compression Tourniquet
  • Balloon Dilation Pressure Pump
  • Microcatheter
  • Micro Guide Wire
  • Contrast Catheter
  • Contrast Guide Wire
  • Guiding Catheter
  • Y-Shaped Connector
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Medtronic
  • Terumo Corporation
  • Boston Scientific
  • Cordis
  • Abbott
  • Merit Medical
  • Curatia Medical
  • ASAHI INTECC
  • Zhejiang Barty Medical Technology
  • OrbusNeich Medical Company
  • MicroPort Scientific Corporation
  • Suzhou Innomed Medical Device
  • Shunmei Medical
  • Shenzhen MicroApproach Medical Technology
  • Shanghai INT Medical Instruments
  • Xiamen New Concept Medical Technology
  • Lepu Medical Technology
  • APT Medical
  • BrosMed Medical
  • Beijing Demax Medical Technology
  • Jiangsu ChangMei Medtech
  • Jiangxi Hongda Medical Equipment Group
  • Changzhou JIUHONG Medical Instrument

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Coronary Pathway Products by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Catheter Sheath Set
  5. 2.2.3 Arterial Compression Tourniquet
  6. 2.2.4 Balloon Dilation Pressure Pump
  7. 2.2.5 Microcatheter
  8. 2.2.6 Micro Guide Wire
  9. 2.2.7 Contrast Catheter
  10. 2.2.8 Contrast Guide Wire
  11. 2.2.9 Guiding Catheter
  12. 2.2.10 Y-Shaped Connector
  13. 2.2.11 Others
  14. 2.3 Coronary Pathway Products by Application
  15. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.3.2 Hospital
  17. 2.3.3 Clinic
  18. 2.3.4 Others
  19. 2.4 Assumptions and Limitations
3 Coronary Pathway Products Breakdown Data by Type
  1. 3.1 Global Coronary Pathway Products Historic Market Size by Type (2021-2026)
  2. 3.2 Global Coronary Pathway Products Forecasted Market Size by Type (2027-2032)
4 Coronary Pathway Products Breakdown Data by Application
  1. 4.1 Global Coronary Pathway Products Historic Market Size by Application (2021-2026)
  2. 4.2 Global Coronary Pathway Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Coronary Pathway Products Market Perspective (2021-2032)
  2. 5.2 Global Coronary Pathway Products Growth Trends by Region
  3. 5.2.1 Global Coronary Pathway Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Coronary Pathway Products Historic Market Size by Region (2021-2026)
  5. 5.2.3 Coronary Pathway Products Forecasted Market Size by Region (2027-2032)
  6. 5.3 Coronary Pathway Products Market Dynamics
  7. 5.3.1 Coronary Pathway Products Industry Trends
  8. 5.3.2 Coronary Pathway Products Market Drivers
  9. 5.3.3 Coronary Pathway Products Market Challenges
  10. 5.3.4 Coronary Pathway Products Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Coronary Pathway Products Players by Revenue
  2. 6.1.1 Global Top Coronary Pathway Products Players by Revenue (2021-2026)
  3. 6.1.2 Global Coronary Pathway Products Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Coronary Pathway Products Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Coronary Pathway Products Head Office and Area Served
  6. 6.4 Global Coronary Pathway Products Players, Product Type & Application
  7. 6.5 Global Coronary Pathway Products Manufacturers Established Date
  8. 6.6 Global Coronary Pathway Products Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Coronary Pathway Products Market Size (2021-2032)
  2. 7.2 North America Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Coronary Pathway Products Market Size by Country (2021-2026)
  4. 7.4 North America Coronary Pathway Products Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Coronary Pathway Products Market Size (2021-2032)
  2. 8.2 Europe Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Coronary Pathway Products Market Size by Country (2021-2026)
  4. 8.4 Europe Coronary Pathway Products Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Coronary Pathway Products Market Size (2021-2032)
  2. 9.2 Asia-Pacific Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Coronary Pathway Products Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Coronary Pathway Products Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Coronary Pathway Products Market Size (2021-2032)
  2. 10.2 South America Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Coronary Pathway Products Market Size by Country (2021-2026)
  4. 10.4 South America Coronary Pathway Products Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Coronary Pathway Products Market Size (2021-2032)
  2. 11.2 Middle East & Africa Coronary Pathway Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Coronary Pathway Products Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Coronary Pathway Products Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Medtronic
  2. 12.1.1 Medtronic Company Information
  3. 12.1.2 Medtronic Business Overview
  4. 12.1.3 Medtronic Revenue in Coronary Pathway Products Business (2021-2026)
  5. 12.1.4 Medtronic Coronary Pathway Products Product Portfolio
  6. 12.1.5 Medtronic Recent Developments
  7. 12.2 Terumo Corporation
  8. 12.2.1 Terumo Corporation Company Information
  9. 12.2.2 Terumo Corporation Business Overview
  10. 12.2.3 Terumo Corporation Revenue in Coronary Pathway Products Business (2021-2026)
  11. 12.2.4 Terumo Corporation Coronary Pathway Products Product Portfolio
  12. 12.2.5 Terumo Corporation Recent Developments
  13. 12.3 Boston Scientific
  14. 12.3.1 Boston Scientific Company Information
  15. 12.3.2 Boston Scientific Business Overview
  16. 12.3.3 Boston Scientific Revenue in Coronary Pathway Products Business (2021-2026)
  17. 12.3.4 Boston Scientific Coronary Pathway Products Product Portfolio
  18. 12.3.5 Boston Scientific Recent Developments
  19. 12.4 Cordis
  20. 12.4.1 Cordis Company Information
  21. 12.4.2 Cordis Business Overview
  22. 12.4.3 Cordis Revenue in Coronary Pathway Products Business (2021-2026)
  23. 12.4.4 Cordis Coronary Pathway Products Product Portfolio
  24. 12.4.5 Cordis Recent Developments
  25. 12.5 Abbott
  26. 12.5.1 Abbott Company Information
  27. 12.5.2 Abbott Business Overview
  28. 12.5.3 Abbott Revenue in Coronary Pathway Products Business (2021-2026)
  29. 12.5.4 Abbott Coronary Pathway Products Product Portfolio
  30. 12.5.5 Abbott Recent Developments
  31. 12.6 Merit Medical
  32. 12.6.1 Merit Medical Company Information
  33. 12.6.2 Merit Medical Business Overview
  34. 12.6.3 Merit Medical Revenue in Coronary Pathway Products Business (2021-2026)
  35. 12.6.4 Merit Medical Coronary Pathway Products Product Portfolio
  36. 12.6.5 Merit Medical Recent Developments
  37. 12.7 Curatia Medical
  38. 12.7.1 Curatia Medical Company Information
  39. 12.7.2 Curatia Medical Business Overview
  40. 12.7.3 Curatia Medical Revenue in Coronary Pathway Products Business (2021-2026)
  41. 12.7.4 Curatia Medical Coronary Pathway Products Product Portfolio
  42. 12.7.5 Curatia Medical Recent Developments
  43. 12.8 ASAHI INTECC
  44. 12.8.1 ASAHI INTECC Company Information
  45. 12.8.2 ASAHI INTECC Business Overview
  46. 12.8.3 ASAHI INTECC Revenue in Coronary Pathway Products Business (2021-2026)
  47. 12.8.4 ASAHI INTECC Coronary Pathway Products Product Portfolio
  48. 12.8.5 ASAHI INTECC Recent Developments
  49. 12.9 Zhejiang Barty Medical Technology
  50. 12.9.1 Zhejiang Barty Medical Technology Company Information
  51. 12.9.2 Zhejiang Barty Medical Technology Business Overview
  52. 12.9.3 Zhejiang Barty Medical Technology Revenue in Coronary Pathway Products Business (2021-2026)
  53. 12.9.4 Zhejiang Barty Medical Technology Coronary Pathway Products Product Portfolio
  54. 12.9.5 Zhejiang Barty Medical Technology Recent Developments
  55. 12.10 OrbusNeich Medical Company
  56. 12.10.1 OrbusNeich Medical Company Company Information
  57. 12.10.2 OrbusNeich Medical Company Business Overview
  58. 12.10.3 OrbusNeich Medical Company Revenue in Coronary Pathway Products Business (2021-2026)
  59. 12.10.4 OrbusNeich Medical Company Coronary Pathway Products Product Portfolio
  60. 12.10.5 OrbusNeich Medical Company Recent Developments
  61. 12.11 MicroPort Scientific Corporation
  62. 12.11.1 MicroPort Scientific Corporation Company Information
  63. 12.11.2 MicroPort Scientific Corporation Business Overview
  64. 12.11.3 MicroPort Scientific Corporation Revenue in Coronary Pathway Products Business (2021-2026)
  65. 12.11.4 MicroPort Scientific Corporation Coronary Pathway Products Product Portfolio
  66. 12.11.5 MicroPort Scientific Corporation Recent Developments
  67. 12.12 Suzhou Innomed Medical Device
  68. 12.12.1 Suzhou Innomed Medical Device Company Information
  69. 12.12.2 Suzhou Innomed Medical Device Business Overview
  70. 12.12.3 Suzhou Innomed Medical Device Revenue in Coronary Pathway Products Business (2021-2026)
  71. 12.12.4 Suzhou Innomed Medical Device Coronary Pathway Products Product Portfolio
  72. 12.12.5 Suzhou Innomed Medical Device Recent Developments
  73. 12.13 Shunmei Medical
  74. 12.13.1 Shunmei Medical Company Information
  75. 12.13.2 Shunmei Medical Business Overview
  76. 12.13.3 Shunmei Medical Revenue in Coronary Pathway Products Business (2021-2026)
  77. 12.13.4 Shunmei Medical Coronary Pathway Products Product Portfolio
  78. 12.13.5 Shunmei Medical Recent Developments
  79. 12.14 Shenzhen MicroApproach Medical Technology
  80. 12.14.1 Shenzhen MicroApproach Medical Technology Company Information
  81. 12.14.2 Shenzhen MicroApproach Medical Technology Business Overview
  82. 12.14.3 Shenzhen MicroApproach Medical Technology Revenue in Coronary Pathway Products Business (2021-2026)
  83. 12.14.4 Shenzhen MicroApproach Medical Technology Coronary Pathway Products Product Portfolio
  84. 12.14.5 Shenzhen MicroApproach Medical Technology Recent Developments
  85. 12.15 Shanghai INT Medical Instruments
  86. 12.15.1 Shanghai INT Medical Instruments Company Information
  87. 12.15.2 Shanghai INT Medical Instruments Business Overview
  88. 12.15.3 Shanghai INT Medical Instruments Revenue in Coronary Pathway Products Business (2021-2026)
  89. 12.15.4 Shanghai INT Medical Instruments Coronary Pathway Products Product Portfolio
  90. 12.15.5 Shanghai INT Medical Instruments Recent Developments
  91. 12.16 Xiamen New Concept Medical Technology
  92. 12.16.1 Xiamen New Concept Medical Technology Company Information
  93. 12.16.2 Xiamen New Concept Medical Technology Business Overview
  94. 12.16.3 Xiamen New Concept Medical Technology Revenue in Coronary Pathway Products Business (2021-2026)
  95. 12.16.4 Xiamen New Concept Medical Technology Coronary Pathway Products Product Portfolio
  96. 12.16.5 Xiamen New Concept Medical Technology Recent Developments
  97. 12.17 Lepu Medical Technology
  98. 12.17.1 Lepu Medical Technology Company Information
  99. 12.17.2 Lepu Medical Technology Business Overview
  100. 12.17.3 Lepu Medical Technology Revenue in Coronary Pathway Products Business (2021-2026)
  101. 12.17.4 Lepu Medical Technology Coronary Pathway Products Product Portfolio
  102. 12.17.5 Lepu Medical Technology Recent Developments
  103. 12.18 APT Medical
  104. 12.18.1 APT Medical Company Information
  105. 12.18.2 APT Medical Business Overview
  106. 12.18.3 APT Medical Revenue in Coronary Pathway Products Business (2021-2026)
  107. 12.18.4 APT Medical Coronary Pathway Products Product Portfolio
  108. 12.18.5 APT Medical Recent Developments
  109. 12.19 BrosMed Medical
  110. 12.19.1 BrosMed Medical Company Information
  111. 12.19.2 BrosMed Medical Business Overview
  112. 12.19.3 BrosMed Medical Revenue in Coronary Pathway Products Business (2021-2026)
  113. 12.19.4 BrosMed Medical Coronary Pathway Products Product Portfolio
  114. 12.19.5 BrosMed Medical Recent Developments
  115. 12.20 Beijing Demax Medical Technology
  116. 12.20.1 Beijing Demax Medical Technology Company Information
  117. 12.20.2 Beijing Demax Medical Technology Business Overview
  118. 12.20.3 Beijing Demax Medical Technology Revenue in Coronary Pathway Products Business (2021-2026)
  119. 12.20.4 Beijing Demax Medical Technology Coronary Pathway Products Product Portfolio
  120. 12.20.5 Beijing Demax Medical Technology Recent Developments
  121. 12.21 Jiangsu ChangMei Medtech
  122. 12.21.1 Jiangsu ChangMei Medtech Company Information
  123. 12.21.2 Jiangsu ChangMei Medtech Business Overview
  124. 12.21.3 Jiangsu ChangMei Medtech Revenue in Coronary Pathway Products Business (2021-2026)
  125. 12.21.4 Jiangsu ChangMei Medtech Coronary Pathway Products Product Portfolio
  126. 12.21.5 Jiangsu ChangMei Medtech Recent Developments
  127. 12.22 Jiangxi Hongda Medical Equipment Group
  128. 12.22.1 Jiangxi Hongda Medical Equipment Group Company Information
  129. 12.22.2 Jiangxi Hongda Medical Equipment Group Business Overview
  130. 12.22.3 Jiangxi Hongda Medical Equipment Group Revenue in Coronary Pathway Products Business (2021-2026)
  131. 12.22.4 Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Product Portfolio
  132. 12.22.5 Jiangxi Hongda Medical Equipment Group Recent Developments
  133. 12.23 Changzhou JIUHONG Medical Instrument
  134. 12.23.1 Changzhou JIUHONG Medical Instrument Company Information
  135. 12.23.2 Changzhou JIUHONG Medical Instrument Business Overview
  136. 12.23.3 Changzhou JIUHONG Medical Instrument Revenue in Coronary Pathway Products Business (2021-2026)
  137. 12.23.4 Changzhou JIUHONG Medical Instrument Coronary Pathway Products Product Portfolio
  138. 12.23.5 Changzhou JIUHONG Medical Instrument Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst